Dossier
pharmaceutical and biotechnology sectors
Coverage of pharmaceutical and biotechnology sectors in the Nexus archive.
- As China plans for demographic crisis, some sectors see opportunity
China is becoming one of the world's fastest-ageing economies, prompting concerns about productivity and population imbalances. Goldman Sachs highlights pharmaceutical and biotechnology sectors as potential beneficiaries, while carmakers and technology hardware manufacturers may face challenges.
- As China plans for demographic crisis, some sectors see opportunity
China's aging economy is causing concerns over productivity and the gap between working and retired populations. Goldman Sachs highlights pharmaceutical and biotechnology sectors as potential beneficiaries, while carmakers and technology hardware manufacturers may face challenges.